Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
153 Cards in this Set
- Front
- Back
IAs were discovered by these 2 types of practitioners in the US and England
|
physicians and dentists
|
|
The most commonly used inhaled anesthetic in modern anesthesia include _____ and ____.
|
a single gas and volatile liquids
(n20, halothane, enflurane, iso, sevo, des) |
|
____ of the IAs meet all of the criteria of an ideal IA, and the _______ differ among the drugs.
|
none, chemical characteristics
|
|
This is the first IA synthesized by the chemist Joseph Priestly. Later, Sir Humphrey Davy observed its ability to produce analgesia and wrote a book about its beneficial effects during surgery. Davy also gassed himself w it for a toothache.
|
N20
|
|
This drug was first used during "frolics" for recreational purposes, and researched by William Morton to show that its effects mimicked those of N20
|
Diethyl ether
|
|
This drug was first used by James Simpson for labor cases, but there were unexplained intraop. deaths of healthy pts and numerous cases of hepatotoxicity
|
chloroform
|
|
These 3 agents were used between 1920 and 1940, had faster and more pleasant induction and emergence. However, they were flammable and halogenated entirely w chlorine, making them toxic
|
ethylene, cyclopropane, divinyl
|
|
Put these in order of introduction: isoflurane, sevoflurane, desflurane
|
first iso, then des, then sevo
|
|
IAs exist in these 2 forms
|
liquid and gas
|
|
Liquid IAs are packaged in
|
glass or plastic containers
|
|
IAs are poured as a liquid into agent-specific _____.
|
vaporizers
|
|
From vaporizers, IAs are carried into the anesthesia breathing circuit as vapors by ____.
|
fresh gas flow
|
|
Early IAs were ____, had prolonged ____ and were ____.
|
unstable, prolonged effect, flammable
|
|
_____ reduces flammability
|
halogenation
|
|
______ reduces solubility
|
fluorination
|
|
_____ groups add stability
|
trifluorcarbon
|
|
______ precipitate arrythmias
|
alkanes
|
|
What are the CV effects of IAs?
|
decrease myocardial contractility, vasodilate, decr CO, incr CVP, decr BP, decr SVR
|
|
What are the resp effects of IAs?
|
depress hypoxic ventillatory drive, incr RR, decr TV, bronchodilate, blunts HPV (incr shunt), incr PaCO2
|
|
What are the cerebral effects of IAs?
|
incr CBF, incr ICP, decr CMRO2
|
|
What is the neuromuscular effect of IAs?
|
augments NDMR, muscle relaxation
|
|
What is the hepatic effect of IAs?
|
decr hepatic blood flow
|
|
What are the renal effects of IAs?
|
decr RBF, decr GFR --> decr U/O
|
|
IAs undergo biotransformation through this enzyme in the hepatic system through _____.
|
CYP 450
Oxidation |
|
Halothane, introduced in _____, was a halogenated ____, preserved in the bottle was ____ to reduce oxidation.
|
1956, alkane, thymol
|
|
_____ is the most commonly used agent worldwide, and is very inexpensive.
|
Halothane
|
|
What are the CV effects of halothane?
|
direct myocardial depression, sensitizes heart to arrythmias
|
|
What are the resp effects of halothane?
|
potent bronchodilator, "Sweet" nonpungent odor
|
|
What are the cerebral effects of halothane?
|
decrease CVR and incr CBF, blunts autoregulation, may alter CPP
|
|
What are the neuromuscular effects of halothane?
|
synergistic NDMR, MH trigger
|
|
What are the renal effects of halothane?
|
decr RBF, decr GFR
|
|
What are the hepatic effects of halothane?
|
decr blood flow, decr drug clearance, primarily excreted by exhalation but also significant liver metabolism
|
|
When is halothane contraindicated?
|
liver dz, intracranal mass, severe hypovolemia
|
|
This complication results from multiple short exposures to a particular IA, and the oxidative metabolite binds to liver cells and causes autoimmune response
|
halothane hepatitis
|
|
All agents except _____ are metabolized by the liver
|
sevoflurane
|
|
___ was introduced in 1972, is similar to isoflurane, and its metabolism to inorganic fluorine can cause seizure activity.
|
enflurane
|
|
This IA was introduced in 1980, has a pungent ether-like odor, and is a chemical isomer of enflurane
|
isoflurane
|
|
CV effects of isoflurane?
|
minimal CV depression, mild incr HR (Dose dep), decr SVR, dilates coronary arteries (Coronary steal)
|
|
Resp effect of isoflurane?
|
irritating to upper airway
|
|
Cerebral effect of isoflurane?
|
greater IMAC = incr CBF/ICP, decr CMRO2 and 2 MAC produces silent EEG
|
|
Neuromuscular effects of isoflurane?
|
MH trigger, synergistic NMDR
|
|
Renal effects of isoflurane?
|
decr RBF ,decr GFR, decr UO
|
|
Hepatic effects of isoflurane?
|
decr blood flow - less than halothane
|
|
____ Was introduced in the 1980s, is halogenated w fluorine, and has nonpungent odor.
|
sevoflurane
|
|
CV effects of sevoflurane?
|
mild depression myocardial contractility, little effect on HR, decr CO, prolonged QT
|
|
Resp effects of sevoflurane?
|
decr RR, bronchodilator
|
|
Cerebral effects of sevoflurane?
|
similar to iso - incr CBF/ICP, decr CMRO2, 2 MAC- silent EEG
|
|
Neuromuscular effects of sevoflurane?
|
augments NDMR
|
|
Renal effects of sevoflurane?
|
slight decr RBF, impaired renal tubule fcn
|
|
Does sevo have hepatic effects?
|
no change in hepatic blood flow
|
|
___ causes an incr in inorganic Flourine ion - inducing renal dysfunction
|
sevoflurane - nephrotoxic
|
|
_____ is the product of degradation of sevo by CO2 absorbent, and is nephrotoxic.
|
compound A
|
|
Sevo-induced nephrotoxicity risk is increased when
|
low flow anesthesia (2L/min), dry CO2 absorbent, when used w current/prior renal dysfunction
|
|
_____ was introduced in the 1980s, and has similar structure to isoflurane. The F atom is substituted w a Cl atom causing profound physical property effects.
|
desflurane
|
|
____ has a very high vapor pressure, requiring a special vaporizer, as it will boil at room temp. It also has low solubility.
|
desflurane
|
|
CV effects of desflurane?
|
dose dependent decr in SVR, CO unchanged, dose dependent incr in HR, doesnt incr coronary artery blood flow
|
|
Resp effects of desflurane?
|
pungent odor, decr TV, depr PaCO2 response, coughing, breath holding, laryngospasm
|
|
Cerebral effects of desflurane?
|
incr CBF, decr CMRO2
|
|
Neuromuscular effect of desflurane?
|
synergistic w NDMR
|
|
Does desflurane have renal or hepatic effects?
|
nope!
|
|
CV effects of N2O
|
decr myocardial contractility but incr overall CV function, induces catecholamines and can cause arrhythmias
|
|
Resp effects of N2O
|
tachypnea, decr TV, doesnt effect MV and PaCO2, inhibits hypoxic drive, incr PVR
|
|
Cerebral effects of N20
|
incr CBF/CBV, increases ICP
|
|
Does N20 have neuromuscular effects?
|
no but enhances muscle relaxers
|
|
During general anesthesia, a known concentration of anesthetic gas is administered via an anesthesia breathing circuit through ____ to the patient.
|
ventilation
|
|
Anesthetic gas enters the lungs, alveoli, passes through the ______ into the blood, to the left side of the heart, and is distributed to _____.
|
alveolar membrane, tissues of the body
|
|
Initially the _______, then the muscles, skin, fat, and connective tissues are perfused w blood/anesthetic gas mixture
|
brain and vital organs
|
|
5 effects of general anesthesia
|
analgesia, amnesia, muscle relaxation, LOC, immobility
|
|
Induction w IA is good for these scenarios
|
pediatrics, mentally challenged, adults w/o IV access
|
|
_____ are the most popular agents for maintenance in adults and peds.
|
IAs
|
|
Stage 1 of anesthesia
|
analgesia: initial analgesia without amnesia (complete or partial inability to remember), ends with analgesia nad amnesia
|
|
Stage 2 of anesthesia
|
excitement: patient is delirious and excited but amnesic, irregular resp, retching and vomitng, incontinence, ends w reestablishment of regular breathing
|
|
Stage 3 of anesthesia
|
surgical anesthesia: begins w recurrence of regular resp and extends to complete cessation of spontaneous resp, 4 planes of stage 3 (Depending on changes in ocular mvmts, eye reflexes, pupil size)
most reliable indications - loss of eyelash reflex, establishment of resp pattern that is regular in rate and depth |
|
stage 4 of anesthesia
|
medullary depression: cessation of spontaneous respiration, severe depression of vasomotor and resp centers in medulla
|
|
Pharmacokinetics
|
how body affects a drug, relationship between drug dose, tissue concentration and elapsed time
|
|
IAs undergo ____ From alveoli into systemic circulation
|
uptake
|
|
Distribution and elimination of IAs is by the ___ or metabolism principally by the ____.
|
lungs, liver
|
|
By controlling the _____ a gradient is created such that the anesthetic is delivered from the machine to the brain.
|
inspired partial pressure
|
|
The primary objective of IA is
|
to achieve a constant and optimal brain partial pressure (PBr) of the anesthetic
|
|
The brain and other tissues equilibrate with the partial pressure of the IA delivered to them by the _____.
|
arterial blood (Pa)
|
|
The blood equilibrates w the _____ of the anesthetic.
|
alveolar partial pressure (PA)
|
|
What is the goal of uptake and distribution of IAs?
|
to achieve brain concentrations of anesthetic agents that promotes amnesia and analgesia
|
|
IAs are standardized according to their
|
MAC (min alveolar concentration)
|
|
How does blood solubility affect FA (Alv conc)?
|
the higher the blood gas concentration, the greater the solubility and uptake by the pulm circulation
|
|
How does alveolar blood flow affect FA (alv conc)?
|
the greater the uptake, the slower the rise of alveolar concentration
|
|
Low cardiac output predisposes the patient to
|
overdose w soluble agents
|
|
Partial pressure difference between the alveoli and venous blood depends on
|
tissue uptake
|
|
A high ____ is necessary during initial admin of IA.
|
FI -- initial high FI offsets impact of uptake into blood and accellerates induction of anesthesia as reflected by rate of incr in PA, this is known as concentration effect
|
|
The higher the FI, the more rapidly the ____ approaches the FI. The higher FI provides anesthetic molecule input to offset ____ And speeds the rate at which the FA increases.
|
FA, uptake
|
|
How does A-a gradient affect Fa (art conc)?
|
due to dead space and venous admixture, there is non-uniform alveolar gas distribution, resulting in VQ mismatch
|
|
The greater the RR and volume, the faster the rate of rise of ____ to _____.
|
alveolar partial pressure, inhaled partial pressure
|
|
_____ agents are taken up by the blood less readily than ___ agents; as a result, the alveolar concentrations rise faster and induction is faster.
|
insoluble, soluble
|
|
The higher the blood gas partition coefficient, the greater the anesthetic's _____ and the greater its ____ by the pulmonary circulation.
|
solubility, uptake
|
|
Lowering of alveolar partial presure by uptake can be countered by
|
increasing alveolar ventilation
|
|
The effect of increasing ventilation will be most obvious in raising the ____ for soluble anesthetics.
|
FA/FI
|
|
For insoluble agents, increasing ventilation has ____ effect.
|
minimal
|
|
___ increases rate of rise of FA; _____ decreases rate of rise of FA.
|
hyperventilation, hypoventilation
|
|
Elimination of rebreathing, high fresh gas flows, low anesthetic-circuit volume, low absorption by the circuit, decr solubility, high cerebral blood flow, and incr ventillation all contribute to
|
speeding induction and recovery
|
|
This is the ability of the high volume uptake of one gas increases the alveolar partial pressure of a second gas-- high inhaled partial pressure of first gas results in higher alveolar partial pressure of the first and second gases
|
second gas effect
|
|
The second gas effect is easily seen with volatile agent coadministration with
|
N20
|
|
Rise of alveolar concentration toward inspired concentration is most rapid with ___ agents such as ____ and least rapid with ____ agents.
|
least blood soluble agents, N20, most blood soluble agents
|
|
Blood gas coefficient of N20
|
.47
|
|
Blood gas coefficient of halothane
|
2.4
|
|
Blood gas coefficient of methoxyflurane
|
12
|
|
Blood gas coefficient of enflurane
|
1.9
|
|
Blood gas coefficient of isoflurane
|
1.4
|
|
Blood gas coefficient of desflurane
|
0.42
|
|
Blood gas coefficient of sevoflurane
|
0.65
|
|
What factors affect the transfer of IA from blood to tissues?
|
tissue solubility, tissue blood flow, and difference between partial pressure of arterial blood and tissue
|
|
what are the vessel rich tisue groups
|
brain, heart, lungs, liver, kidney, endocrine organs
|
|
What arethe vessel poor groups of tissue
|
bone, ligament, hair, teeth, cartilage
|
|
What is the order of blood flow compartment filling?
|
vessel rich > muscle > fat > vessel poor
|
|
What effect does N20 have on bone marrow?
|
suppression
|
|
Elimination of IAs is dependent on the
|
concentration
|
|
Discontinuing the IA leads to a decrease in the partial pressure in the alveoli and causes the agent to ______
|
diffuse away from the tissue
|
|
3 elimination routes
|
biotransformation (CYP450),
Transcutaneous loss (insignificant), exhalation |
|
This is the most important route for elimination
|
exhalation
|
|
Factors that speed induction also speed elimination, such as
|
incr FGF, incr ventilation, high CBF
|
|
IAs are eliminated in the order from
|
vessel rich to vessel poor tissue groups
|
|
Pharmacodynamics
|
how the drug affects the body, study of drug action and toxic effects
|
|
This theory states that IAs work on specific GABA receptors by a neuroinhibitory neurotransmitter
|
agent specific theory
|
|
This theory states that all anesthetic agents affect cells the same way because potency is related to lipid solubility (Based on meyer-overton rule)
|
unitary theory
|
|
This theory states that lipophilic agents bind to and expand the cell membrane, making them less functional
|
critical volume hypothesis
|
|
____ may work by disturbing membrane shape, altering membrane conductance (disturbed ion channels, altered synaptic functions) or altering ligand gated ion channels (GABA enhancement, NMDA receptors)
|
IAs
|
|
MAC
|
concentration at which 50% of the population wil move under surgical stimulation -- doesnt include addition of other agents like narcotics
|
|
MAC 95%
|
1.3,
has been shown to inhibit mvmt in 95% of all pts |
|
MAC awake
|
typically 0.3-0.5% of the MAC
|
|
MAC BAR (don't move at all)
|
1.5
|
|
Factors that affect mac
|
temp, age (young incr, decr 6% per decade), intoxication/drugs (acute/chronic), anemia, hypotension, pregnancy
|
|
Highest MAC need is in
|
infant up to 6 months
|
|
Mac decreases ___% for each degree decrease in C temp
|
7%
|
|
MAC of N20
|
104
|
|
MAC of desflurane
|
6
|
|
MAC of sevoflurane
|
2
|
|
MAC of enflurane
|
1.63
|
|
MAC of isoflurane
|
1.2
|
|
MAC of halothane
|
0.75
|
|
The higher the MAC, the ___ potent the agent
|
less
|
|
The more potent the agent, the ___ lipid/oil soluble.
|
more
|
|
The higher the blood gas coefficient, the more ____ and ___ the agent.
|
soluble, slower
|
|
Since the MAC of N2O is 105%, you cant give 1 mac because
|
it would be a hypoxic mixture -- must always give at least 30% Fi02
|
|
____ is the only inorganic compound used, and it supports combustion. It is insoluble compared to other IAs
|
N20
|
|
N20 will fill air containing cavities, and is contraindicated in
|
pneumothorax, venous air embolism, pneumocephalus, inner ear sx, bowel obstruction
|
|
Renal effects of N20
|
decr RBF and GFR
|
|
Hepatic effects of N20
|
mild decr blood flow
|
|
GI effects of N20
|
incr n/v
|
|
metabolism of N20
|
cyp450 in the liver
|
|
N20 inhibits ____ synthesis, which is important w pregnant women and can cause congenital anomalies or spontaneous abortion.
|
Vit B12
|
|
This is the reverse of the second gas effect, and occurs when the elimination of N2O from the alveoli proceeds at a greater rate than other agents - N20 dilutes alveolar air and available O2 resulting in hypoxia
|
diffusion hypoxia
|
|
N2 is ___ less soluble in blood than N20.
|
34x
|
|
This condition is genetically linked, involves the uncoupling of the RYR causing prolonged skeletal muscle contraction (massive release of Ca2+ from SR of skeletal muscle causing contraction and heat production) -- can be fatal!
|
MH
|
|
Triggers for MH
|
succinylcholine and IAs
|
|
This toxic molecule can build up as a result of desflurane degradation by old baralyme, and can be avoided by regularly changing baralyme.
|
CO
|